Paper Details

  1. Home
  2. Paper Details

Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.

Author: BergerW E, FinemanS M, LiebermanP, MilesR M

Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Azelastine hydrochloride is an H1-receptor antagonist with antiinflammatory properties. It can be used for the treatment of seasonal allergic rhinitis, either as monotherapy or in combination with intranasal corticosteroids.
Paper Details　
Original Abstract of the Article :
Azelastine hydrochloride is an H1-receptor antagonist with antiinflammatory properties that is available in the US as Astelin Nasal Spray for the treatment of seasonal allergic rhinitis. The symptoms of seasonal allergic rhinitis can initially be treated with monotherapy using either an antihistamin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s1081-1206(10)63161-4

データ提供：米国国立医学図書館（NLM）

Azelastine Nasal Spray: A Potent Oasis in the Desert of Seasonal Allergies

Seasonal allergies, with their itchy eyes and runny noses, can be a real nuisance. This research focuses on azelastine nasal spray, an antihistamine with anti-inflammatory properties, and its effectiveness in treating seasonal allergic rhinitis. The researchers compared azelastine monotherapy to a combination therapy of loratadine tablets and beclomethasone nasal spray in patients with seasonal allergies. The study found that azelastine monotherapy was comparable in effectiveness to the combination therapy, indicating its potential as a stand-alone treatment option for seasonal allergies.

Azelastine: A Single Solution for Seasonal Allergies

This research suggests that azelastine nasal spray can be an effective treatment for seasonal allergies, offering a single-agent solution that is comparable in effectiveness to a combination therapy. These findings are promising for individuals seeking a simpler and more convenient approach to managing their allergy symptoms.

Navigating the Desert of Allergies: Finding a Path to Relief

The desert of seasonal allergies can be a challenging landscape for individuals who suffer from these common conditions. This research on azelastine nasal spray provides a potential oasis, offering a single-agent treatment option that can effectively manage allergy symptoms without the need for multiple medications. By understanding the different treatment options available and discussing them with their healthcare providers, individuals can navigate the desert of allergies with greater comfort and ease.

Dr. Camel's Conclusion

This research on azelastine nasal spray is like finding a cool spring in the desert of seasonal allergies. It offers a single-agent solution that can effectively manage allergy symptoms, providing relief for those seeking a simpler and more convenient approach to treatment.

Date :
  1. Date Completed 1999-07-08
  2. Date Revised 2019-11-03
Further Info :

Pubmed ID

10400480

DOI: Digital Object Identifier

10.1016/s1081-1206(10)63161-4

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.